• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[用于CYP2C9*3(1075A/C,rs1057910)和VKORC1(-1639A/G,rs9923231)基因分型的高分辨率熔解方法的开发]

[Development of the high resolution melting method for genotyping CYP2C9*3 (1075A/C, rs1057910) and VKORC1 (-1639A/G, rs9923231)].

作者信息

Cui Guang-lin, Ding Hu, Xu Yu-jun, Chen Chen, Wang Dao-wen

机构信息

Department of Cardiology, Institute of Hypertension, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Jun;40(6):477-81.

PMID:22943641
Abstract

OBJECTIVE

To establish the high-resolution melting curve (HRM) approach for genotyping CYP2C9*3 (1075A/C, rs1057910) and VKORC1 (-1639A/G, rs9923231) and explore its value on estimation of the Warfarin initial dose in comparison with various traditional genotyping methods.

METHODS

CYP2C9*3 (1075A/C, rs1057910) and VKORC1 (-1639A/G, rs9923231) genotyping was detected in 100 patients receiving Warfarin therapy by the newly developed HRM method and traditional genotyping methods including PCR-restriction fragment length polymorphism (PCR-RFLP), TaqMan probe and DNA sequencing.

RESULTS

The results of the genotypes obtained from above mentioned methods to detect CYP2C9*3 (1075A/C, rs1057910) and VKORC1 (-1639A/G, rs9923231) were similar and consistent. The HRM method is simpler, more economical, and faster compared to the traditional methods. The frequencies of the VKORC1-1639 AA, AG, GG genotypes from these 100 clinical samples were 73 (73%), 23 (23%), 4 (4%), respectively; Frequencies of the CYP2C9 1075 AA, AC, CC genotypes were 94(94%), 6 cases (6%), 0, respectively.

CONCLUSIONS

HRM approach can effectively detect CYP2C93 (1075A/C, rs1057910) and VKORC1 (-1639A/G, rs9923231) polymorphisms and this method is simpler, more economical, and faster compared to the traditional methods for detecting CYP2C93 (1075A/C, rs1057910) and VKORC1 (-1639A/G, rs9923231) polymorphisms.

摘要

目的

建立用于细胞色素P450 2C9*3(1075A/C,rs1057910)和维生素K环氧化物还原酶复合体1(VKORC1)(-1639A/G,rs9923231)基因分型的高分辨率熔解曲线(HRM)方法,并与各种传统基因分型方法比较,探讨其在华法林初始剂量估算中的价值。

方法

采用新开发的HRM方法及包括聚合酶链反应-限制性片段长度多态性(PCR-RFLP)、TaqMan探针和DNA测序在内的传统基因分型方法,对100例接受华法林治疗的患者进行细胞色素P450 2C9*3(1075A/C,rs1057910)和VKORC1(-1639A/G,rs9923231)基因分型检测。

结果

上述检测细胞色素P450 2C9*3(1075A/C,rs1057910)和VKORC1(-1639A/G,rs9923231)的方法所获得的基因型结果相似且一致。与传统方法相比,HRM方法更简便、经济且快速。这100例临床样本中VKORC1 -1639 AA、AG、GG基因型的频率分别为73(73%)、23(23%)、4(4%);细胞色素P450 2C9 1075 AA、AC、CC基因型的频率分别为94(94%)、6例(6%)、0。

结论

HRM方法可有效检测细胞色素P450 2C93(1075A/C,rs1057910)和VKORC1(-1639A/G,rs9923231)多态性,且与检测细胞色素P450 2C93(1075A/C,rs1057910)和VKORC1(-1639A/G,rs9923231)多态性的传统方法相比,该方法更简便、经济且快速。

相似文献

1
[Development of the high resolution melting method for genotyping CYP2C9*3 (1075A/C, rs1057910) and VKORC1 (-1639A/G, rs9923231)].[用于CYP2C9*3(1075A/C,rs1057910)和VKORC1(-1639A/G,rs9923231)基因分型的高分辨率熔解方法的开发]
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Jun;40(6):477-81.
2
Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin.华法林治疗患者中 VKORC1(G-1639A 和 C1173T)和 CYP2C9*3 的临床相关性。
J Clin Pharm Ther. 2012 Apr;37(2):232-6. doi: 10.1111/j.1365-2710.2011.01262.x. Epub 2011 Apr 20.
3
The influence of CYP2C9 and VKORC1 gene polymorphisms on optimal warfarin doses after heart valve replacement.CYP2C9 和 VKORC1 基因多态性对心脏瓣膜置换术后华法林最佳剂量的影响。
Medicina (Kaunas). 2011;47(1):25-30.
4
ARMS test for diagnosis of CYP2C9 and VKORC1 mutation in patients with pulmonary embolism in Han Chinese.用于诊断汉族肺栓塞患者 CYP2C9 和 VKORC1 突变的 ARMS 试验。
Pharmacogenomics. 2010 Jan;11(1):113-9. doi: 10.2217/pgs.09.138.
5
Prevalence of VKORC1 and CYP2C9 gene polymorphisms in Indian population and its effect on warfarin response.印度人群中维生素K环氧化物还原酶复合体亚单位1(VKORC1)和细胞色素P450 2C9(CYP2C9)基因多态性的患病率及其对华法林反应的影响。
J Assoc Physicians India. 2012 Dec;60:34-8.
6
[Association between CYP2C9 and VKORC1 genetic polymorphism and warfarin dose requirements].[细胞色素P450 2C9(CYP2C9)和维生素K环氧化物还原酶复合物亚单位1(VKORC1)基因多态性与华法林剂量需求之间的关联]
Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Feb;36(2):137-40.
7
Frequency of VKORC1 (C1173T) and CYP2C9 genetic polymorphisms in Egyptians and their influence on warfarin maintenance dose: proposal for a new dosing regimen.VKORC1(C1173T)和 CYP2C9 基因多态性在埃及人中的频率及其对华法林维持剂量的影响:新给药方案的建议。
Int J Lab Hematol. 2012 Oct;34(5):517-24. doi: 10.1111/j.1751-553X.2012.01426.x. Epub 2012 Apr 26.
8
[Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy].[CYP2C9和VKORC1基因多态性对华法林治疗起始阶段反应的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Oct;39(10):929-35.
9
VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weight, and age are important predictors for warfarin maintenance doses in patients with mechanical heart valve prostheses in southwest China.VKORC1-1639G>A、CYP2C9、EPHX1691A>G 基因型、体重和年龄是中国西南部机械心脏瓣膜置换术后患者华法林维持剂量的重要预测因子。
Eur J Clin Pharmacol. 2010 Dec;66(12):1217-27. doi: 10.1007/s00228-010-0863-9. Epub 2010 Sep 15.
10
[Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage].[莫斯科人群静脉血栓栓塞并发症患者中CYP2C9和VKORC1基因多态性:对抗凝治疗稳定性和出血频率的影响]
Ter Arkh. 2011;83(6):59-65.

引用本文的文献

1
High resolution melting method to detect single nucleotide polymorphism of VKORC1 and CYP2C9.采用高分辨率熔解曲线法检测VKORC1和CYP2C9的单核苷酸多态性。
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2558-64. eCollection 2014.